Recruiting
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
NCT05718323
- Conditions
- SCLC,Extensive Stage, SLFN11-positive
- Locations
-
- CHU - Angers Angers, France
- Centre Hospitalier d'Avignon Avignon, France
- Caen - CHU Caen, France
- Lyon - Centre Léon Bérard Lyon, France